Abiopharma

Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zeta Global Announces Olympic Gold Medalist, Entrepreneur and Founder Lindsey Vonn as Second Zeta Live 2026 Keynote Speaker

Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2026 Financial Results

8x8, Inc. Announces Participation in Evercore Global TMT Conference

Sonos Announces Participation in Rosenblatt’s 6th Annual Technology Virtual Summit

Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Curbline Properties Second Quarter 2026 Investment and Capital Markets Update

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)